ube2wb Antibody

What is ube2wb and what are its primary functions in zebrafish models?

Ube2wb (Probable ubiquitin-conjugating enzyme E2 W-B) is a zebrafish homolog of the ubiquitin-conjugating enzyme E2W family. This enzyme functions within the ubiquitin-proteasome system, accepting ubiquitin from E1 enzymes and transferring it to E3 ligases or substrate proteins. The enzyme belongs to a conserved family present across vertebrates and plays critical roles in protein degradation pathways, potentially including N-terminal ubiquitination similar to its human homolog UBE2W . In zebrafish (Danio rerio), ube2wb (gene ID: 692325) is encoded by the flj11011l gene and is also known as zgc:136503 . While specific zebrafish functions are still being elucidated, related ubiquitin-conjugating enzymes in humans are involved in DNA repair, transcriptional regulation, and protein quality control.

How do ube2wb antibodies differ from other UBE2 family antibodies in terms of applications?

Ube2wb antibodies are specifically designed to target the zebrafish ubiquitin-conjugating enzyme E2 W-B, making them ideal for studying this particular enzyme in zebrafish models. Unlike antibodies for other UBE2 family members such as UBE2B (which functions in DNA repair and histone modification) or UBE2N (implicated in Alzheimer's disease pathology) , ube2wb antibodies target a distinct E2 enzyme with potentially specialized functions in zebrafish. The specificity is determined by the immunogen used - typically recombinant Danio rerio ube2wb protein . Applications are generally limited to ELISA and Western blotting techniques for zebrafish samples, whereas other UBE2 family antibodies like human UBE2B antibodies may have broader applications including chromatin immunoprecipitation (ChIP), immunohistochemistry (IHC), and immunocytochemistry (ICC-IF) .

What are the optimal conditions for using ube2wb antibodies in Western blot applications with zebrafish samples?

When performing Western blot analysis with ube2wb antibodies on zebrafish samples:

• Sample preparation: Extract total protein from zebrafish tissues or cells using a standard lysis buffer containing protease inhibitors.

• Protein loading: Load 20-30 μg of total protein per lane, similar to protocols used for other UBE2 family proteins .

• Gel selection: Use 12% SDS-PAGE gels as these provide optimal separation for lower molecular weight proteins (~17 kDa size range of ube2wb) .

• Transfer conditions: Transfer to PVDF or nitrocellulose membranes using standard transfer buffers.

• Blocking: Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute ube2wb antibody at 1:1000 ratio in blocking buffer and incubate overnight at 4°C (following similar protocols to UBE2B antibodies) .

• Detection: Use appropriate secondary antibodies (anti-rabbit IgG, since most ube2wb antibodies are rabbit polyclonal ) and enhanced chemiluminescence for visualization.

• Controls: Include recombinant ube2wb protein as a positive control and pre-immune serum as a negative control, which are typically provided with the antibody .

The expected band size should be verified against the predicted molecular weight of zebrafish ube2wb.

How can researchers validate the specificity of commercial ube2wb antibodies for zebrafish samples?

To validate the specificity of ube2wb antibodies for zebrafish research:

• Positive control testing: Use the recombinant ube2wb protein (often supplied with the antibody) as a positive control in Western blot or ELISA .

• Pre-immune serum comparison: Compare results with the pre-immune serum (negative control) provided with the antibody to confirm signal specificity .

• Knockdown validation: Perform siRNA/morpholino knockdown of ube2wb in zebrafish cells or embryos and confirm reduced signal intensity in Western blot.

• Cross-reactivity assessment: Test the antibody against related E2 enzymes (like ube2wa) to ensure it doesn't cross-react with similar proteins.

• Multiple antibody comparison: If available, compare results from different ube2wb antibody clones or sources.

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry analysis to confirm the identity of the captured protein.

• Species specificity checking: Confirm the antibody works specifically with zebrafish samples and verify if it cross-reacts with mammalian homologs.

These validation steps are critical because many commercial antibodies may have unintended cross-reactivity that could compromise experimental results.

How can ube2wb antibodies be used to study N-terminal ubiquitination pathways in zebrafish models?

Based on knowledge of the human UBE2W homolog, which catalyzes non-canonical N-terminal ubiquitination , researchers can use ube2wb antibodies to investigate similar pathways in zebrafish through these approaches:

• Substrate identification: Perform immunoprecipitation with ube2wb antibodies followed by mass spectrometry to identify potential substrates with N-terminal ubiquitination in zebrafish.

• N-terminal diglycine remnant detection: Adapt techniques similar to those used for human UBE2W studies, where specialized antibodies recognize N-terminal diglycine remnants after tryptic digestion . This approach can be modified to work in conjunction with ube2wb antibodies in zebrafish models.

• Enzyme-substrate co-localization: Use ube2wb antibodies in combination with antibodies against predicted substrates to determine co-localization in cell or tissue samples.

• Activity assays: Combine ube2wb immunoprecipitation with in vitro ubiquitination assays to assess N-terminal ubiquitination activity on candidate substrates.

• Developmental studies: Use ube2wb antibodies to track the expression and localization of the enzyme during different developmental stages in zebrafish to correlate with potential N-terminal ubiquitination events.

When designing these experiments, researchers should consider that while the human UBE2W substrate repertoire has been partially characterized using specialized antibody toolkits , zebrafish substrates may differ and require additional validation.

What are the experimental approaches for studying the relationship between ube2wb and neurological development in zebrafish using ube2wb antibodies?

To investigate ube2wb's potential role in neurological development, researchers can employ these methodological approaches:

• Temporal expression profiling: Use ube2wb antibodies in Western blot analysis of zebrafish brain tissue at different developmental stages to determine expression patterns during neural development.

• Spatial localization: Perform immunohistochemistry or immunofluorescence using ube2wb antibodies to map the distribution of the enzyme in developing zebrafish brain regions.

• CRISPR/Cas9 knockout studies: Generate ube2wb knockout zebrafish lines and use ube2wb antibodies to confirm protein absence, then characterize neurological phenotypes.

• Co-immunoprecipitation studies: Use ube2wb antibodies to pull down protein complexes from neuronal tissues to identify interacting proteins involved in neurological development.

• Comparative analysis with UBE2N: Given that UBE2N has been implicated in Alzheimer's disease pathology , researchers could investigate potential functional relationships between ube2wb and UBE2N homologs in zebrafish neurological processes.

• Ubiquitination substrate identification: Combine ube2wb antibody immunoprecipitation with proteomic analysis to identify neuronal substrates that may be regulated by ube2wb-mediated ubiquitination.

• Pharmacological intervention: Assess how inhibitors of the ubiquitin pathway affect ube2wb expression and function in neurological tissue, using ube2wb antibodies to measure protein levels.

This approach is supported by evidence that ubiquitin-conjugating enzymes like human UBE2W may be involved in neurite outgrowth , suggesting potential neuro-developmental roles for zebrafish homologs.

What are common issues with ube2wb antibody specificity in zebrafish research and how can they be addressed?

Common specificity issues with ube2wb antibodies include:

• Cross-reactivity with ube2wa: Zebrafish possess two related UBE2W homologs (ube2wa and ube2wb) , and antibodies may cross-react. To address this:

  • Perform careful sequence analysis to identify unique epitopes

  • Test antibodies against recombinant ube2wa and ube2wb proteins separately

  • Use genetic models with specific knockout of each paralog as controls

• Non-specific binding: When multiple bands appear in Western blots:

  • Optimize blocking conditions (try different blocking agents: 5% milk, 3-5% BSA, or commercial blockers)

  • Increase antibody dilution (test range from 1:500 to 1:5000)

  • Add 0.1% Tween-20 to antibody diluent to reduce non-specific binding

  • Increase washing steps duration and number

• Inconsistent results between samples:

  • Standardize protein extraction protocols

  • Use fresh samples and avoid repeated freeze-thaw cycles

  • Include positive controls (recombinant ube2wb) and negative controls (pre-immune serum) in each experiment

  • Consider tissue-specific optimization of protocols

• Batch-to-batch variability:

  • Request antibodies from the same lot when possible

  • Validate each new batch against previous successful experiments

  • Consider developing in-house monoclonal antibodies for long-term projects

• Epitope masking:

  • If ube2wb forms complexes with other proteins, epitopes may be masked

  • Try different sample preparation methods (various detergents, denaturing conditions)

  • Test multiple antibodies targeting different regions of ube2wb

How can researchers optimize immunoprecipitation protocols using ube2wb antibodies for identifying novel interaction partners?

For optimizing immunoprecipitation (IP) with ube2wb antibodies:

• Antibody selection and preparation:

  • Choose affinity-purified antibodies when available

  • Cross-link antibodies to beads (Protein A/G) to prevent antibody contamination in eluates

  • Use 2-5 μg antibody per mg of total protein extract

• Lysis buffer optimization:

  • Test multiple lysis buffers with different detergent strengths:

    • Mild conditions: 0.5% NP-40 or 1% Triton X-100 for preserving protein complexes

    • Stringent conditions: Add 0.1-0.5% SDS for reducing non-specific binding

  • Always include protease inhibitors, phosphatase inhibitors, and deubiquitinase inhibitors (N-ethylmaleimide) to preserve ubiquitination status

• IP protocol refinement:

  • Pre-clear lysates with Protein A/G beads to reduce non-specific binding

  • Optimize antibody-lysate incubation time (4-16 hours at 4°C)

  • Implement stringent washing steps (increasing salt concentration gradually)

  • Consider using formaldehyde cross-linking to capture transient interactions

• Elution strategies:

  • Compare different elution methods:

    • Low pH elution (glycine buffer, pH 2.5)

    • Competitive elution with immunizing peptide

    • SDS sample buffer elution for maximum recovery

  • For MS analysis, avoid detergents incompatible with mass spectrometry

• Validation controls:

  • Include IgG control IP from the same species as the ube2wb antibody

  • Perform parallel IP with pre-immune serum

  • Include ubiquitination pathway controls (E1, other E2s) to distinguish specific from general interactions

• Interaction verification:

  • Confirm interactions by reciprocal IP when possible

  • Validate key interactions with orthogonal methods (Y2H, proximity ligation assay)

  • For ubiquitination studies, include ubiquitin antibodies in Western blot analysis of IP samples

This optimized approach will help identify genuine interaction partners while minimizing background and artifacts.

How do the functional properties of zebrafish ube2wb compare with human UBE2W in ubiquitination research?

The functional comparison between zebrafish ube2wb and human UBE2W reveals important evolutionary and mechanistic insights:

Researchers using ube2wb antibodies should consider these comparative aspects when designing experiments and interpreting results in the context of evolutionary conservation and divergence between zebrafish and human systems.

What methodological considerations are important when using ube2wb antibodies to investigate ubiquitination pathways in both pathological and normal states?

When investigating ubiquitination pathways in different physiological contexts:

This methodological framework enables robust investigation of ube2wb's roles in both normal physiology and pathological states while maintaining experimental rigor.

How can advanced proteomic techniques be combined with ube2wb antibodies to comprehensively map N-terminal ubiquitination sites in zebrafish models?

Integrated approaches for mapping N-terminal ubiquitination in zebrafish include:

• Specialized antibody development:

  • Design zebrafish-specific antibodies that recognize N-terminal diglycine remnants after tryptic digestion, similar to those developed for human UBE2W studies

  • Create antibody panels targeting different regions of ube2wb to distinguish various functional states

• IP-MS workflow optimization:

  • Perform tandem immunoprecipitation:

    • First IP: ube2wb antibody to pull down enzyme complexes

    • Second IP: Using anti-ubiquitin antibodies on ube2wb IP products

  • Employ specialized proteolytic strategies:

    • Use multiple proteases beyond trypsin (LysC, GluC) to generate diverse peptide fragments

    • Optimize digestion conditions to preserve modification sites

• Mass spectrometry techniques:

  • Implement parallel reaction monitoring (PRM) for targeted detection of predicted N-terminal ubiquitinated peptides

  • Apply SILAC or TMT labeling to compare wildtype vs. ube2wb-deficient samples

  • Utilize specialized fragmentation techniques (ETD/EThcD) that better preserve post-translational modifications

  • Develop custom search algorithms for identifying non-canonical ubiquitination sites

• Functional validation pipeline:

  • Create a systematic workflow:

    • MS-identified sites → site-directed mutagenesis → functional testing

    • Correlate identified sites with protein structural data

    • Assess evolutionary conservation of identified sites across species

• Spatial proteomic integration:

  • Combine tissue-specific ube2wb antibody staining with laser capture microdissection

  • Perform region-specific proteomics to map N-terminal ubiquitination patterns across tissues

  • Correlate with in situ hybridization data for substrate expression

This integrated approach provides a comprehensive strategy for characterizing the N-terminal ubiquitinome in zebrafish, potentially revealing conserved mechanisms relevant to human biology.

What are the considerations for applying AI and machine learning approaches to analyzing ube2wb antibody-generated data in large-scale zebrafish studies?

Implementing AI/ML for ube2wb antibody data analysis requires:

• Data acquisition standardization:

  • Establish consistent protocols for:

    • Sample preparation (tissue collection, fixation, protein extraction)

    • Antibody concentrations and incubation conditions

    • Image acquisition parameters for microscopy

    • Western blot exposure and quantification settings

  • Implement automated liquid handling for high-throughput screening

  • Develop standardized data formats and metadata annotation

• Training dataset development:

  • Create validated ground-truth datasets with:

    • Manual expert annotation of positive/negative signals

    • Graduated intensity standards for quantitative assessment

    • Diverse sample types covering multiple experimental conditions

  • Include controls for batch effects and technical variations

• ML model selection and optimization:

  • For image analysis (IHC/IF):

    • Convolutional neural networks for pattern recognition

    • Instance segmentation models for cellular/subcellular localization

    • Transfer learning approaches using pre-trained models

  • For expression data:

    • Regression models for quantitative Western blot analysis

    • Classification models for phenotypic correlations

    • Time-series models for developmental studies

• Biologically-informed feature engineering:

  • Incorporate domain knowledge when designing features:

    • Subcellular compartment ratios

    • Co-localization metrics with known partners

    • Temporal expression patterns during development

    • Correlation with ubiquitination substrate candidates

• Validation and interpretation frameworks:

  • Implement cross-validation strategies specific to antibody-based data

  • Develop explainable AI approaches that align with biological mechanisms

  • Create interactive visualization tools for researchers to explore model outputs

  • Establish benchmarking against traditional analysis methods

• Integration with multi-omics data:

  • Design pipelines that combine antibody-derived data with:

    • Transcriptomics (RNA-seq, single-cell RNA-seq)

    • Proteomics (global proteome, ubiquitinome)

    • Phenomics (morphological and behavioral data)

  • Implement multi-modal learning approaches

This framework enables researchers to leverage AI/ML for extracting maximum value from ube2wb antibody experiments while maintaining biological relevance and experimental rigor.